Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Shares Outstanding (Weighted Average) (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $70.7 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $70.7 million; the TTM value through Feb 2026 reached $70.7 million, changed 0.0%, while the annual FY2025 figure was $70.7 million, 49.38% up from the prior year.
  • Shares Outstanding (Weighted Average) was $70.7 million for Q1 2026 at Cannabis Suisse, roughly flat from $70.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $70.7 million in Q3 2024, with the low at $31.1 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $53.4 million across 5 years, with a median of $46.3 million in 2024.
  • The largest annual shift saw Shares Outstanding (Weighted Average) decreased 9.88% in 2022 before it surged 59.71% in 2024.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $40.7 million in 2022, then rose by 12.75% to $45.8 million in 2023, then surged by 54.2% to $70.7 million in 2024, then changed by 0.0% to $70.7 million in 2025, then changed by 0.0% to $70.7 million in 2026.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $70.7 million in Q1 2026, $70.7 million in Q4 2025, and $70.7 million in Q3 2025.